A

Adaptimmune Ltd

448 employees

Adaptimmune develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Health Care

Medical

Biopharma

Date founded

2008

Funding rounds raised

Total raised

$104M

from 9 investors over 9 rounds

A

Adaptimmune Ltd raised $104M on September 25, 2014

Investors: Merlin Nexus, Wellington Management, OrbiMed Advisors, venBio Partners, Ridgeback Capital Management LLC, QVT Financial LLP, Novo Holdings and University of Oxford

A

Adaptimmune Ltd raised undisclosed on January 1, 2014

Investors: Sahsen Ventures, LLC